Lv2
140 积分 2026-08-02 加入
Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD
2小时前
求助中
Iron Regulation by Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Patients with Chronic Kidney Disease
9天前
已完结
Four-Week Studies of Oral Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia
11天前
已完结
Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial
22天前
已关闭
Transdermal Androgen Therapy to Augment EPO in the Treatment of Anemia of Chronic Renal Disease
22天前
已完结
Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA)
22天前
已完结
The first human cell line-derived erythropoietin, epoetin-delta (Dynepo), in the management of anemia in patients with chronic kidney disease
22天前
已完结
Epoetin delta in the management of renal anaemia: results of a 6-month study
22天前
已完结
Bioavailability of Iron in Hemodialysis Patients Treated With Erythropoietin: Evidence for the Inhibitory Role of Aluminum
22天前
已完结
皖公网安备34019202002308
